Skip to main content
International Journal of Food Science logoLink to International Journal of Food Science
. 2023 Jan 31;2023:3298723. doi: 10.1155/2023/3298723

Probiotic Properties of Exopolysaccharide-Producing Bacteria from Natto

Vongsathorn Ngampuak 1, Acharawan Thongmee 1, Napapan Pongpoungphet 2, Kanda Wongwailikhit 3, Panan Kanchanaphum 4,
PMCID: PMC9904927  PMID: 36762123

Abstract

Natto is a traditional Japanese food made from soybeans fermented with Bacillus subtilis var. natto. It is also a famous food in Thailand. Potential probiotics were screened from natto. Bacillus subtilis strain VN5 produced the most quantity of exopolysaccharide (EPS), so it was selected to study the properties of microbial EPS and probiotics. The Fourier transform infrared spectrometer or FT-IR spectroscopy confirmed the presence of carboxyl and hydroxyl groups. The patterns of FT-IR and levans are similar. The basic properties of probiotics were revealed. The 90% of VN5 strain resisted lysozyme within 30 min. VN5 survived under acidic conditions (pH 1-6), and the survival rate in 0.3%, 0.5%, and 1% bile solutions for 24 h was 100%. Unfortunately, VN5 did not inhibit the growth of Escherichia coli, Staphylococcus aureus, and Salmonella typhi. Gamma hemolysis was determined in VN5 strain. The finding on Bacillus subtilis strain (VN5) from natto paves the way to a high potential, useful new strain of probiotics.

1. Introduction

Microbial exopolysaccharides (EPS) are the outer cellular high atomic mass metabolites excreted by microorganism such as bacteria, yeasts, fungi, molds, and blue-green algae [1]. EPS plays an important role against many cellular functions, such as cell eating, phage defense, osmatic stress aggregation of bacterial cells, and surface adherence [2]. They could either be found as capsular polysaccharides which are covalently linked to cell surface or loosely bound or secreted outside during cell growth [3, 4]. EPS are used for several medical and industrial applications as medical coating devices, scaffolds, drug delivery systems, surgical sealants [5], gelling agents or biostabilizers [6], depollution agents, antioxidants, anti-inflammatory agents [7], antithrombotics, and anticancer agent [8]. In the food industry, they are used as stabilizers, flavorings, color carriers, and food thickeners [9]. In the last decade, several microorganisms have been proposed as potential EPS producers. Moreover, gram-positive Bacillus species have been potential as EPS-producing bacteria [10].

Probiotics are live microorganisms, which, when administered in adequate amounts, confer a health benefit on the host. Microbes used as probiotics are derived from different genera and species.

Natto is one of the most favorite fermented foods in Asia. They contain several kinds of useful probiotics which can stimulate the immune system and inhibit the growth of pathogen [11]. Moreover, some probiotics may secrete the EPS [12].

This study investigated potential bacteria in natto which could produce the EPS and evaluated probiotic properties of isolated bacteria and the characterization of EPS.

2. Material and Methods

2.1. EPS-Producing Bacteria Screening and Isolation

2.1.1. Bacteria Screening

Fermented bean curd and natto were obtained from a market in Chiang Mai Province, Thailand. A 10-fold dilution of the fermented bean curd and natto was performed with distilled water. After that, they were incubated at 37°C for 20 min, spread on tryptic soy agar (TSA) (Becton Dickinson GmbH, Germany) plates, and incubated at 37°C for 18 h. The colonies were picked and used for a further study.

2.1.2. Identification of Bacteria

Isolated pure colonies of bacterial culture were identified by 16S rRNA as described by Dorn-In et al. [13]. The DNA was extracted using a GF-1 Bacterial DNA Extraction kit (Vivantis). The polymerase chain reaction (PCR) was performed in a BIO-RAD MJ Mini Personal Thermal Cycler. The cycle conditions consisted of a single initial denaturation at 95°C for 5 min, followed by 40 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec and final extension at 72°C for 5 min, respectively. The amplicon was sent to Solutions for Genetic Technologies in South Korea for sequencing.

First, the resulting sequences were checked and aligned using the BioEdit 7.0 sequence alignment editor (Isis Pharmaceuticals, Inc., Carlsbad, CA, USA). Then, they were compared with a homologous sequence stored on the GenBank database. Finally, the Basic Local Alignment Search Tool (BLAST) program, downloaded from the National Center for Biotechnology Information (NCBI) website, was used to evaluate the sequences. The MEGAX version 10.1.8 was used for constructing a phylogenic tree. Through the neighbor joining method by which a 1,000 bootstrap value was set, 16S rRNA of Staphylococcus aureus strain DSM 20231 (MN652637) was an outgroup gram-positive Bacillus, and Escherichia coli strain JCM1649 (AB24291) was an outgroup gram-negative Bacillus.

2.2. Bacterial Growth Condition and EPS Production

The isolated bacteria were cultured in tryptic soy broth (TSB) (Becton Dickinson GmbH, Germany) with 20% sucrose added. The pH value of the cultures was adjusted to 6.8 and allowed to grow at 37°C, for 24 hr. The growth curve was then measured. EPS production was carried out by using a 30 ml TSB medium with 20% sucrose in a 100 ml Erlenmeyer flask in batch culture. One ml of inoculum was added to the media. The inoculum had a cell count of about 106 cells/ml−1. After that, it was incubated in a shaking incubator at 200 rpm for 48 hr at 37°C.

2.3. Isolation of EPS

After the cultivation of bacteria in the TSB, the cell culture was centrifuged at 5,000 g for 10 min. The supernatant was collected. Then, the 3 volumes of 95% ethanol were added, and the cell culture was stored at 4°C for 24 hr. After that, the solution was centrifuged at 12,000 g for 5 min at 4°C for precipitating the EPS polymer. Consequently, the polymer was washed with 70% ethanol, and the remained ethanol evaporated at room temperature.

2.4. Characterization of EPS by FT-IR Analysis of Crude-Purified EPS

The 10 mg EPS sample was homogenized and analyzed using Spectrum 100 Optica-PerkinElmer with a frequency range of 4,000-650 cm−1.

2.5. Basic Properties of Probiotic

2.5.1. Lysozyme Tolerance Activity of the Isolated Bacteria

The bacterial cells were tested for lysozyme tolerance activity by using sterile electrolyte solution (SES; CaCl2 0.22 g/l, NaCl 6.2 g/l, KCl 2.2 g/l, and NaHCO3 1.2 g/l) and lysozyme 100 mg/l [14] and incubated at 37°C for 5, 15, 30, and 60 min, respectively. After that, cell counting was performed. The control group comprised bacterial cells cultured in nonlysozyme condition.

2.5.2. Acidic Tolerance Activity of the Isolated Bacteria

The bacterial cells were tested for acidic tolerance activity by culturing the cells in nutrient broth or NBs (Becton Dickinson GmbH, Germany) of which pH values were adjusted to 1, 2, 3, 4, 5, and 6 by 1 N HCl. Then, they were incubated at 37°C for 24 hr, and counted cells (CFU/ml) were compared with those in the control group (culture in TSB pH 7) [15, 16].

2.5.3. Bile Tolerance Activity of the Isolated Bacteria

The bacterial cells were tested for bile tolerance activity by culturing the cells in NBs which contained 0.3%, 0.5%, and 1% bile. Then, they were incubated at 37°C for 24 hr. After that, 100 μl of the bacterial solution was used to count cells (CFU/ml) compared with the control group (cultured without bile) [17].

2.5.4. Pathogenic Bacterial Inhibition of the Isolated Bacteria by the Well Diffusion Method

We used an agar well diffusion assay adapted from Barefoot and Klaenhammer [18]. The isolated bacteria were cultured in nutrient agar (NA) and incubated at 37°C for 24 hr. Subsequently, the pathogenic bacteria used in this study were Escherichia coli, Staphylococcus aureus, and Salmonella typhi. Each pathogenic bacterium was placed on an isolated bacteria plate using a 3-way swab technique, and the agar was punctured. The diameter of the punctured well was about 0.5 cm. Then, 50 μl bacterial solution in each well was taken (the concentration of the cell count was about 106 cells/ml−1), and the bacteria were cultured in the NB medium at 37°C for 24 hr. An inhibition zone was determined by observing a clear zone around the punctured well.

2.5.5. Hemolysis Assay

The hemolysis testing was conducted on BD™ Columbia agar with 5% sheep blood (Becton Dickinson GmbH, Germany) to determine the type of hemolysis. VN2, VN3, VN5, and VN7 were cultured in BD™ Columbia agar with 5% sheep blood agar and incubated at 37°C for 24 hr for the determination of the hemolysis pattern. Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus epidermidis were used as the positive control of α-hemolysis, β-hemolysis, and γ-hemolysis, respectively.

3. Results

3.1. Isolation and Identification of Bacteria

There were 4 isolated colonies, which were selected in the EPS production step as shown in Figure 1(a). VN2, VN3, VN5 and VN7 were white, slim and glossy. All of them had rod shapes as shown in Figure 1(b). After sequencing the 16S rRNA gene, the alignment of this gene is shown in Table 1 and Figure 2.

Figure 1.

Figure 1

(a) Colony of VN2, VN3, VN5, and VN7. (b) Microscope image of rod shapes of VN2, VN3, VN5, and VN7.

Table 1.

The accession number of VN2, VN3, VN5, and VN7.

Colony number Submission Isolates Accession number
VN2 SUB9848071 Bacillus subtilis strain VN2 16S rRNA gene, partial sequence MZ389241
VN3 SUB9849022 Bacillus aureus strain VN3 16S rRNA gene, partial sequence MZ389932
VN5 SUB9849390 Bacillus subtilis strain VN516S rRNA gene, partial sequence MZ389888
VN7 SYB9849510 Bacillus licheniformis strain VN7 16S rRNA gene, partial sequence MZ389979

Figure 2.

Figure 2

Phylograms of 16S rRNA sequence-based phylogenic trees of VN2, VN3, VN5, and VN7.

Table 1 and Figure 2 show that VN2 and VN5 were Bacillus subtilis, VN3 was Bacillus aureus, and VN7 was Bacillus licheniformis.

3.2. Bacterial Growth Condition and EPS Production

Figure 3 shows the exponential phases of VN2, VN3, VN5, and VN7. The exponential phases of VN2, VN3, VN5, and VN7 were 89.62 min, 100.96 min, 40.99 min, and 67.18 min, respectively. So it meant that VN5 grew most rapidly to the log phase while VN3 grew most slowly. However, the growth rate of VN3 was the best while VN7 was the worst.

Figure 3.

Figure 3

Growth curve of the isolated bacteria for 24 hr.

After the EPS production from VN2, VN3, VN5, and VN7, EPS precipitation was performed as shown in Figure 4. The polymers of EPS in all cultures were observed, and the white fluffy particle appeared on the top of the cultures. The dry weights of EPS from VN2, VN3, VN5, and VN7 were 3.2, 1.07, 7.2, and 3.47 g/l, respectively.

Figure 4.

Figure 4

Polymers of EPS in the 30 ml cultures of VN2, VN3, VN5, and VN7, respectively.

3.3. FT-IR Spectral Analysis

Fourier transform infrared spectroscopy (FT-IR) was used to identify the functional groups of the EPS produced from bacteria. FT-IR spectra were recorded from 4,000 cm−1 to 650 cm−1 to identify the functional groups of EPS from VN5 as shown in Figure 5. There were 7 major peaks that are shown in Figure 5.

Figure 5.

Figure 5

FT-IR analysis of VN5 EPS.

3.4. Basic Properties of Probiotics

3.4.1. Lysozyme Tolerance Activity

From Figure 6, all VN2, VN3, VN5, and VN7 resisted lysozyme within 15 minutes. However, after 30 minutes of lysozyme incubation, the percentages of the surviving bacteria slightly dropped by 2-8%.

Figure 6.

Figure 6

Lysozyme tolerance activity of VN2, VN3, VN5, and VN7, respectively.

3.4.2. Acidic Tolerance Activity

From Figure 7, VN2, VN3, VN5, and VN7 survived in all acidic environments (pH 1-6) after incubated for 24 hr. Especially, VN2 was the best survivor strain which could grow in lower pH values.

Figure 7.

Figure 7

Acidic tolerance activity.

3.4.3. Bile Tolerance Activity

All bile concentration did not affect the bacterial growth as shown in Figure 8. When compared with Salmonella typhi (representation of gram-negative bacteria) and Bacillus subtilis (representation of gram-positive bacteria), bile could retard the growth of both bacteria.

Figure 8.

Figure 8

Bile tolerance activity.

3.4.4. Pathogen Bacterial Inhibition by Well Diffusion Method

Figure 9 shows that no inhibition zones were observed since all cultures (VN2, VN3, VN5, and VN7) could not inhibit Escherichia coli, Staphylococcus aureus, and Salmonella typhi.

Figure 9.

Figure 9

Pathogen bacterial inhibition of VN2, VN3, VN5, and VN7, respectively.

3.4.5. Hemolysis Assay

From the blood agar, VN2 and VN3 strains were α-hemolysis as shown in Figure 10 while VN5 and VN7 were γ-hemolysis in which there was no change in the agar under and surrounding the colonies.

Figure 10.

Figure 10

The control of three types of hemolysis (a). Hemolysis assays of VN2, VN3, VN5, and VN7, respectively (b).

4. Discussion

In this study, the isolated bacteria from fermented bean curd and natto were Bacillus subtilis (VN2 and VN5), Bacillus aureus (VN3) and Bacillus licheniformis (VN7). Our results were similar to the study of Dos Santos et al. that [9] natto contained Bacillus subtilis [9, 19]. Noteworthy, Dimidi et al. [20] and Takagi et al. [21] studied probiotics in fermented soy and fermented bean curd and found that the fermented foods contained Lactobacillus acidophilus, Lactobacillus bulgaricus, Streptococcus lactis, Bacillus subtilis, and Bacillus amyloliquefaciens. Natto is a traditional Japanese fermented soybean produced through the fermentation of cooked soybeans with Bacillus subtilis. The fermentation of natto produces a number of bioactive factors such as nattokinase, bacillopeptidase F, vitamin K2, and dipicolinic acid [22]. Particularly, nattokinase is an enzyme of the subtilisin family produced by Bacillus subtilis [23] and can be isolated from natto [24]. Nattokinase has direct in vitro [24] and in vivo [25] fibrinolytic enzyme activity, increasing tissue plasminogen activators [26] and reducing platelet aggregation [27].

Noteworthy, the TSB with 20% sucrose added was the bacterial culture medium used to produce EPS in this study because Trabelsi et al. [28] reported that the sucrose was favorably used by many Bacillus species. Shih et al. [29] showed that Bacillus subtilis can produce ELS in the sucrose-rich growth medium. In addition, Lee et al. [30] reported that Bacillus amyloliquefaciens grew well in LB broth containing 0.3% oxgall. Another evidence that showed the importance of sucrose on media for EPS production in Bacillus subtilis is the study of Shih et al. [31]. They suggested that in the sucrose-rich environments, Bacillus subtilis (natto) Takahashi, a commercial natto starter, is able to selectively produce up to 50 g/l of EPS levan during batch fermentation [31]. The EPS found in this study may be levan for the reason that it was produced from Bacillus species, especially Bacillus subtilis [9]. In addition, the pattern of FT-IR of the EPS of VN5 was similar to levan [9, 32]. Levan is an EPS predominantly composed of D-fructose residues joined by glycosidic bonds β (2→1) and terminal glucose residue [9, 33]. The levan has wild industrial and technological applications. It highlights on the food industry as a stabilizer, flavor, color carrier, and food thickener [34]. After determining the function groups of EPS by FT-IR, there were 7 major peaks. A broad peak was observed at 3,270.43 cm−1 due to the presence of hydroxyl groups, and the polysaccharide characteristics of Bacillus tequilensisEPS were confirmed [35, 36]. The peak at 1,634.69 cm−1 revealed the presence of the carboxylate group and the characteristics of the IR absorption frequency band of polysaccharides [33]. The absorption peaks at 1,542.93 cm−1 and 1,402.90 cm−1 were the symmetric stretching vibration of carboxyl groups. The bands at 1,22.95 cm−1 and 1,055.77 cm−1 were attributed to the stretch of C-O and C-O-C which ascertained the existence of polymer [36, 37]. The peak at 842.36 cm−1 represented the characteristic peak of heteropolysaccharide compounds [37].

To assess probiotic potential, VN2, VN3, VN5, and VN7 were tested in acidic environment, bile and lysozyme tolerance, and pathogen inhibition activity. All VN strains could survive in acidic environment. The finding was consistent with the finding of Lee et al. [30] that Bacillus amyloliquefaciens LN survived in the culture media at pH 2.0 for 3 hr. In addition, another probiotic, Leuconostoc mesenteroides, had the survival rates more than 80% in acidic environments (pH 2 and 3) [38]. In bile tolerance activity, VN 2, 3, 5, and 7 demonstrated absolute bile tolerance in 0.3, 0.5, and 1% bile which was noticeable. This result was similar to Walker and Gilliland [39] and Vinderola and Reinheimer [40]. The bacteria which have high tolerance to bile salt were effective in bile salt deconjugation and consequently effective in lowering serum cholesterol. Another interesting property of probiotic is lysozyme tolerance. Özkan et al. and Mengesha et al. [41, 42] revealed that Lactobacillus (L.) strains isolated from traditional Turkish Tulum cheeses showed moderate lysozyme tolerance while VN2, VN3, VN5, and VN7 demonstrated strong lysozyme tolerance in 30 min and moderate tolerance in 60 min similar to Özkan et al. [41]. Furthermore, Guariglia-Oropeza and Helmann [43] mentioned that the extracytoplasmic factor on (ECF) sigma (σ) factors especially σw had involved in lysozyme resistance property. The σw regulon includes at least 60 genes that inactivate, sequester, or eliminate toxic compounds form cell, and its expression is induced by variety of cell envelope active compounds, detergent, and alkali stress ([4446]). It meant that the mechanism for lysozyme resistance in Bacillus is very complicated. Unfortunately, VN2, VN3, VN5, and VN7 did not show antibacterial activity in Escherichia coli, Staphylococcus aureus, and Salmonella typhi, while Bacillus subtilis isolated from natto by Dimidi et al. [20] revealed that this bacteria was the important factor in treating Streptococcus pneumoniae infections. Therefore, in further studies, Streptococcus pneumoniae could be performed for antibacterial activity testing. For safety assessment, all VN strains showed gamma hemolysis identifying that they were safe.

5. Conclusion

In this study, Bacillus subtilis strain (VN5) isolated from natto in the northern part of Thailand may be a good candidate for probiotic bacteria because it could produce a high amount of EPS which has the same FT-IR pattern of levan. In addition, this VN5 strain had basic properties of probiotic such as lysozyme tolerance, acidic tolerance, bile tolerance, and safety. So, VN5 and its EPS will allow the feasibility of the industrial applications in the future.

Acknowledgments

The authors would like to sincerely thank Mr. Stewart Miller and Center of Translation and Language Services, Rangsit University, for critically correcting English grammar. This work was supported by the Research Institute of Rangsit University, Thailand (Grant no. 47/2563).

Data Availability

All data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  • 1.Zhang J., Cao Y., Wang J., et al. Physicochemical characteristics and bioactivities of the exopolysaccharide and its sulphated polymer from Streptococcus thermophilus GST-6. Carbohydrate Polymers . 2016;146:368–375. doi: 10.1016/j.carbpol.2016.03.063. [DOI] [PubMed] [Google Scholar]
  • 2.Angelin J., Kavitha M. Exopolysaccharides from probiotic bacteria and their health potential. International Journal of Biological Macromolecules . 2020;162:853–865. doi: 10.1016/j.ijbiomac.2020.06.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schmid J., Sieber V., Rehm B. Bacterial exopolysaccharides: biosynthesis pathways and engineering strategies. Frontiers in Microbiology . 2015;6:p. 496. doi: 10.3389/fmicb.2015.00496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang J., Zhao X., Tian Z., Yang Y., Yang Z. Characterization of an exopolysaccharide produced by Lactobacillus plantarum YW11 isolated from Tibet Kefir. Carbohydrate Polymers . 2015;125:16–25. doi: 10.1016/j.carbpol.2015.03.003. [DOI] [PubMed] [Google Scholar]
  • 5.Nadzir M. M., Nurhayati R. W., Idris F. N., Nguyen M. H. Biomedical applications of bacterial exopolysaccharides: a review. Polymers . 2021;13(4):p. 530. doi: 10.3390/polym13040530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huang K. H., Chen B. Y., Shen F. T., Young C. C. Optimization of exopolysaccharide production and diesel oil emulsifying properties in root nodulating bacteria. World Journal of Microbiology and Biotechnology . 2012;28(4):1367–1373. doi: 10.1007/s11274-011-0936-7. [DOI] [PubMed] [Google Scholar]
  • 7.Diao Y., Xin Y., Zhou Y., et al. Extracellular polysaccharide from Bacillus sp. strain LBP32 prevents LPS-induced inflammation in RAW 264.7 macrophages by inhibiting NF-κB and MAPKs activation and ROS production. International Immunopharmacology . 2014;18(1):12–19. doi: 10.1016/j.intimp.2013.10.021. [DOI] [PubMed] [Google Scholar]
  • 8.Nwodo U. U., Green E., Okoh A. I. Bacterial exopolysaccharides: functionality and prospects. International Journal of Molecular Sciences . 2012;13(12):14002–14015. doi: 10.3390/ijms131114002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dos Santos L. F., De Melo F. B. C., Paiva W. M., Borsato D., Da Silva M. C. C., Celligoi M. P. C. Characterization and optimization of levan production by Bacillus subtilis NATTO. Romanian Biotechnological Letter . 2013;18(4):8413–8422. [Google Scholar]
  • 10.Pei F., Ma Y., Chen X., Liu H. Purification and structural characterization and antioxidant activity of levan from Bacillus megaterium PFY-147. International Journal of Biological Macromolecules . 2020;161:1181–1188. doi: 10.1016/j.ijbiomac.2020.06.140. [DOI] [PubMed] [Google Scholar]
  • 11.Alvarez-Olmos M. I., Oberhelman R. A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clinical Infectious Diseases . 2001;32(11):1567–1576. doi: 10.1086/320518. [DOI] [PubMed] [Google Scholar]
  • 12.Sørensen H. M., Rochfort K. D., Rochfort K. D., Maye S. Exopolysaccharides of lactic acid bacteria: production, purification and health benefits towards functional food. Nutrients . 2022;14(14):p. 2938. doi: 10.3390/nu14142938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dorn-In S., Bassitta R., Schwaiger K., Bauer J., Hölzel C. S. Specific amplification of bacterial DNA by optimized so-called universal bacterial primers in samples rich of plant DNA. Journal of Microbiological Methods . 2015;113:50–56. doi: 10.1016/j.mimet.2015.04.001. [DOI] [PubMed] [Google Scholar]
  • 14.Vizoso-Pinto M. G., Franz C. M. A. P., Schillinger U., Holzapfel W. Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products. International Journal of Food Microbiology . 2006;109(3):205–214. doi: 10.1016/j.ijfoodmicro.2006.01.029. [DOI] [PubMed] [Google Scholar]
  • 15.Liang T. W., Tseng S. C., Wang S. L. Production and characterization of antioxidant properties of exopolysaccharide(s) from Peanibacillus mucilaginosus TKU032. Marine Drugs . 2016;14(2):p. 40. doi: 10.3390/md14020040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zaid A. A. Study the effect of probiotic bacteria isolated from foods on pathogens. Biomedical Research . 2018;29(12):2509–2515. doi: 10.4066/biomedicalresearch.29-17-3692. [DOI] [Google Scholar]
  • 17.Coelho M. C., Malcata F. X., Silva C. C. Lactic acid bacteria in raw-milk cheeses: from starter cultures to probiotic functions. Foods . 2022;11(15):p. 2276. doi: 10.3390/foods11152276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Barefoot S. F., Klaenhammer T. R. Purification and characterization of the Lactobacillus acidophilus bacteriocin lactacin B. Antimicrobial Agents and Chemotherapy . 1984;26(3):328–334. doi: 10.1128/AAC.26.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ruiz Sella S. R. B., Bueno T., de Oliveira A. A. B., Karp S. G., Soccol C. R. Bacillus subtilis natto as a potential probiotic in animal nutrition. Critical Reviews in Biotechnology . 2021;41(3):355–369. doi: 10.1080/07388551.2020.1858019. [DOI] [PubMed] [Google Scholar]
  • 20.Dimidi E., Cox S., Rossi M., Whelan K. Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease. Nutrients . 2019;11(8):p. 1806. doi: 10.3390/nu11081806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Takagi A., Kano M., Kaga C. Possibility of breast cancer prevention: use of soy isoflavones and fermented soy beverage produced using probiotics. International Journal of Molecular Sciences . 2015;16(12):10907–10920. doi: 10.3390/ijms160510907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cao Z. H., Green-Johnson J. M., Buckley N. D., Lin Q. Y. Bioactivity of soy-based fermented foods: a review. Biotechnology Advances . 2019;37(1):223–238. doi: 10.1016/j.biotechadv.2018.12.001. [DOI] [PubMed] [Google Scholar]
  • 23.Wang C., Du M., Zheng D., Kong F., Zu G., Feng Y. Purification and characterization of nattokinase from Bacillus subtilis natto B-12. Journal of Agricultural and Food Chemistry . 2009;57(20):9722–9729. doi: 10.1021/jf901861v. [DOI] [PubMed] [Google Scholar]
  • 24.Fujita M., Nomura K., Hong K., Ito Y., Asada A., Nishimuro S. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochemical and Biophysical Research Communications . 1993;197(3):1340–1347. doi: 10.1006/bbrc.1993.2624. [DOI] [PubMed] [Google Scholar]
  • 25.Xu J., Du M., Yang X., Chen Q., Chen H., Lin D. H. Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis. Acta Haematologica . 2014;132(2):247–253. doi: 10.1159/000360360. [DOI] [PubMed] [Google Scholar]
  • 26.Yatagai C., Maruyama M., Kawahara T., Sumi H. Nattokinase-promoted tissue plasminogen activator release from human cells. Pathophysiology of Haemostasis and Thrombosis . 2009;36(5):227–232. doi: 10.1159/000252817. [DOI] [PubMed] [Google Scholar]
  • 27.Jang J. Y., Kim T. S., Cai J., et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Laboratory Animal Research . 2013;29(4):221–225. doi: 10.5625/lar.2013.29.4.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Trabelsi I., Slima S. B., Chaabane H., Riadh B. S. Purification and characterization of a novel exopolysaccharides produced by Lactobacillus sp. Ca6. International Journal of Biological Macromolecules . 2015;74:541–546. doi: 10.1016/j.ijbiomac.2014.12.045. [DOI] [PubMed] [Google Scholar]
  • 29.Shih I.-L., Chen L. D., Wu J. Y. Levan production using Bacillus subtilis natto cells immobilized on alginate. Carbohydrate Polymers . 2010;82(1):111–117. doi: 10.1016/j.carbpol.2010.04.030. [DOI] [Google Scholar]
  • 30.Lee A., Cheng K. C., Liu J. R. Isolation and characterization of a Bacillus amyloliquefaciens strain with zearalenone removal ability and its probiotic potential. PLoS One . 2017;12(8, article e0182220) doi: 10.1371/journal.pone.0182220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Shih I.-L., Yu Y. T., Shieh C. J., Hsieh C. Y. Selective production and characterization of levan by Bacillus subtilis (natto) Takahashi. Journal of Agricultural and Food Chemistry . 2005;53(21):8211–8215. doi: 10.1021/jf058084o. [DOI] [PubMed] [Google Scholar]
  • 32.Rani R. P., Anandharaj M., Sabhapathy P., Ravindran A. D. Physiochemical and biological characterization of novel exopolysaccharide produced by Bacillus tequilensis FR9 isolated from chicken. International Journal of Biological Macromolecules . 2017;96:1–10. doi: 10.1016/j.ijbiomac.2016.11.122. [DOI] [PubMed] [Google Scholar]
  • 33.Öner E. T., Hernández L., Combie J. Review of levan polysaccharide: from a century of past experiences to future prospects. Biotechnology Advances . 2016;34(5):827–844. doi: 10.1016/j.biotechadv.2016.05.002. [DOI] [PubMed] [Google Scholar]
  • 34.Duboc P., Mollet B. Applications of exopolysaccharides in the dairy industry. International Dairy Journal . 2001;11:759–768. doi: 10.1016/s0958-6946(01)00119-4. [DOI] [Google Scholar]
  • 35.Saravanan C., Shetty P. K. H. Isolation and characterization of exopolysaccharide from Leuconostoc lactis KC117496 isolated from idli batter. International Journal of Biological Macromolecules . 2016;90:100–106. doi: 10.1016/j.ijbiomac.2015.02.007. [DOI] [PubMed] [Google Scholar]
  • 36.Meng X., Luosang D., Meng S., et al. The structural and functional properties of polysaccharide foulants in membrane fouling. Chemosphere . 2021;268, article 129364 doi: 10.1016/j.chemosphere.2020.129364. [DOI] [PubMed] [Google Scholar]
  • 37.Sirajunnisa A. R., Vijayagopal V., Sivaprakash B., Viruthagiri T., Surendhiran D. Optimization, kinetics and antioxidant activity of exopolysaccharide produced from rhizosphere isolate, Pseudomonas fluorescens CrN6. Carbohydrate Polymers . 2016;135:35–43. doi: 10.1016/j.carbpol.2015.08.080. [DOI] [PubMed] [Google Scholar]
  • 38.Cele N., Nyide B., Khoza T. In vitro characterisation of potential probiotic bacteria isolated from a naturally fermented carrot and ginger brine. Fermentation . 2022;8(10):p. 534. doi: 10.3390/fermentation8100534. [DOI] [Google Scholar]
  • 39.Walker D. K., Gilliland S. E. Relationships among bile tolerance, bile salt deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. Journal of Dairy Science . 1993;76(4):956–961. doi: 10.3168/jds.S0022-0302(93)77422-6. [DOI] [PubMed] [Google Scholar]
  • 40.Vinderola C. G., Reinheimer J. A. Lactic acid starter and probiotic bacteria: a comparative "in vitro" study of probiotic characteristics and biological barrier resistance. Food Research International . 2003;36(9-10):895–904. doi: 10.1016/S0963-9969(03)00098-X. [DOI] [Google Scholar]
  • 41.Özkan E. R., Demirci T., Öztürk H. I., Akın N. Screening Lactobacillus strains from artisanal Turkish goatskin casing Tulum cheeses produced by nomads via molecular and in vitro probiotic characteristics. Journal of the Science of Food and Agriculture . 2021;101(7):2799–2808. doi: 10.1002/jsfa.10909. [DOI] [PubMed] [Google Scholar]
  • 42.Mengesha Y., Tebeje A., Tilahun B. A review on factors influencing the fermentation process of Teff (Eragrostis teff) and other cereal-based Ethiopian injera. International Journal of Food Science . 2022;2022:10. doi: 10.1155/2022/4419955.4419955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Guariglia-Oropeza V., Helmann J. D. Bacillus subtilis σ confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids. Journal of Bacteriology . 2011;193(22):6223–6232. doi: 10.1128/JB.06023-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Butcher B. G., Helmann J. D. Identification of Bacillus subtilis σW-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by Bacilli. Molecular Microbiology . 2006;60(3):765–782. doi: 10.1111/j.1365-2958.2006.05131.x. [DOI] [PubMed] [Google Scholar]
  • 45.Cao M., Kobel P. A., Morshedi M. M., Wu M. F. W., Paddon C., Helmann J. D. Defining the Bacillus subtilis σW regulon: a comparative analysis of promoter consensus search, run-off transcription/macroarray analysis (ROMA), and transcriptional profiling approaches. Journal of Molecular Biology . 2002;316(3):443–457. doi: 10.1006/jmbi.2001.5372. [DOI] [PubMed] [Google Scholar]
  • 46.Helmann J. D. Deciphering a complex genetic regulatory network: the Bacillus subtilis σW protein and intrinsic resistance to antimicrobial compounds. Science Progress . 2006;89(3-4):243–266. doi: 10.3184/003685006783238290. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data used to support the findings of this study are included within the article.


Articles from International Journal of Food Science are provided here courtesy of Wiley

RESOURCES